FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,075,724 | -16.9% | 602,153 | +84.5% | 0.19% | -22.2% |
| Q3 2022 | $7,315,000 | +12.2% | 326,419 | +24.0% | 0.24% | +7.2% |
| Q2 2022 | $6,521,000 | -17.9% | 263,156 | +28.4% | 0.22% | +13.2% |
| Q1 2022 | $7,946,000 | +1.8% | 204,945 | +53.6% | 0.20% | +22.4% |
| Q4 2021 | $7,805,000 | +76.8% | 133,401 | +79.1% | 0.16% | +91.7% |
| Q3 2021 | $4,415,000 | – | 74,492 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |